On December 11, 2018 our shareholders approved the 2019 Omnibus Incentive Plan. The 2019 Omnibus Incentive Plan was most recently amended and restated effective December 16, 2025 ("Restated Plan"). The Restated Plan continues to allow us to grant or issue stock options, restricted share awards, restricted stock unit awards, and other equity awards to key employees and to non-employee directors. The Restated Plan increased the number of shares of our common stock that may be awarded and issued under the Restated Plan by 820,000. As of August 29, 2026, 2.7 million shares remain available for future issuance, which will be increased by the number of shares subject to any outstanding awards under the Restated Plan or the 2014 Omnibus Equity, Performance Award, and Incentive Compensation Plan (“2014 Plan”) that expire or are forfeited or canceled. Full value awards granted under the Restated Plan will count as two shares against the share reserve. Outstanding Awards under the 2014 Plan will continue to be subject to the terms of the 2014 Plan, as applicable. Shares remaining available for future awards under the 2014 Plan were not carried over into the Restated Plan.

Our outstanding options have a 10-year term. Options issued to employees generally vest over a three-year period in equal annual installments on the annual anniversary dates following the grant date. Share awards generally vest based either upon continued employment ("time-based") or upon attainment of specified goals. Outstanding share awards that are not time-based vest at the end of a three-year incentive period based upon the achievement of company performance goals ("performance-based"). Generally, time-based share awards vest in the same manner as options, except for time-based share awards to directors, which vest one year from the grant date.

Dividend equivalents are granted in connection with restricted stock unit awards, which accrue on the same basis as dividends payable on the shares of our common stock during the vesting period. No dividend equivalents are paid on any restricted stock units that are forfeited prior to the vesting date.

Our Employee Stock Purchase Plan ("ESPP") permits employees to purchase our common stock at a 15% discount from the lesser of the market price on the first day of semi-annual purchase periods and the market price on the last day of such purchase periods. In Fiscal 2026 and 2025, approximately 85,000 shares and 75,000 shares, respectively, were purchased through the ESPP. Plan participants had accumulated $0.4 million and $0.5 million for periods ended August 29, 2026 and August 30, 2025, respectively, to purchase our common stock pursuant to this plan. As of August 29, 2026, a total of 750,000 shares were authorized for issuance and approximately 394,000 shares remain available for future issuance under the ESPP.

Compensation expense associated with share-based awards is recognized over the requisite service or performance period of the award, unless accelerated by certain retirement eligibility provisions. Forfeitures are recorded when they occur. Total stock-based compensation expense for the past three fiscal years consisted of the following components:


(in millions)	2026		2025		2024
Share awards:
Time-based	$	12.2	$	11.2	$	11.6
Performance-based	1.4		1.6		0.5
Stock options	2.3		1.8		1.4
Other(1)	1.0		1.2		1.1
Total stock-based compensation expense	$	16.9	$	15.8	$	14.6

(1) Includes stock-based compensation expense related to Board of Directors stock award expense and ESPP expense. Directors may elect to defer all or part of their annual retainer into a deferred compensation plan. The plan allows them to defer into either money units or stock units.

The fair value of time-based restricted stock units is determined based on the closing market price of our stock on the date of grant. A summary of the status of nonvested time-based restricted stock units at August 29, 2026, and changes during Fiscal 2026, is as follows:


	Shares(1)	Weighted Average Fair Value
Outstanding at August 30, 2025	423,620	$	55.63
Granted	399,397	$	30.97
Vested	(176,511)	$	57.70
Forfeited/canceled	(49,407)	$	38.66
Outstanding at August 29, 2026	597,099	$	39.92

As of August 29, 2026, there was $7.7 million of unrecognized compensation expense related to nonvested time-based restricted stock units that are expected to be recognized over a weighted average period of 0.9 years. The total fair value of restricted stock units vested during Fiscal 2026, 2025, and 2024 was $5.3 million, $10.6 million, and $8.4 million, respectively.

The fair value of performance-based restricted stock units is determined based on the closing market price of our stock on the date of grant. A summary of the status of our nonvested performance-based restricted stock units at August 29, 2026, and changes during Fiscal 2026, is as follows:


	Shares(1)	Weighted Average Fair Value
Outstanding at August 30, 2025	306,363	$	58.08
Granted	199,435	$	30.75
Vested	—	$	—
Forfeited/canceled	(134,030)	$	55.53
Outstanding at August 29, 2026	371,768	$	44.34

As of August 29, 2026, there was $2.1 million of unrecognized compensation expense related to nonvested performance-based restricted stock units that are expected to be recognized over a weighted average period of 1.3 years. There were no performance-based restricted stock units vested during Fiscal 2026. The total fair value of performance-based restricted stock units vested during Fiscal 2025 and 2024 was $1.4 million, and $4.5 million, respectively.

A summary of stock option activity for Fiscal 2026 is as follows:


	Stock Options(1)	Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value
Outstanding at August 30, 2025	484,239	$	49.94
Granted	180,017	$	30.75
Exercised	(27,300)	$	23.78
Forfeited/canceled	(26,404)	$	47.03
Outstanding at August 29, 2026	610,552	$	45.58	5.9	$	—

Exercisable at August 29, 2026	370,466	$	50.10	4.1	$	—


Valuation Assumptions(1)	2026			2025			2024
Expected dividend yield	4.6		%	2.3		%	2.1		%
Risk-free interest rate(2)	3.6		%	3.8		%	4.6		%
Expected life of stock options (in years)(3)	5			5			5
Expected stock price volatility(4)	50.2		%	49.2		%	50.8		%
Weighted average fair value of options granted	$	10.22		$	23.61		$	25.10